Abstract
There is a significant requirement within the United Kingdom for tissue grafts from living donors. To ensure safety, blood samples from these donors are tested for pathogens at donation, and at 180 days post donation. Nucleic acid amplification technology (NAT) permits more sensitive detection of pathogens in blood samples than serum antigen testing. NAT testing can be applied to samples from living tissue donors to eliminate the need to re-test these donors 180 days post-donation before grafts can be implanted. This has major financial and operational advantages for a tissue bank, and this manuscript describes how NAT testing was assessed and implemented by NHSBT Tissue Services. When compared to traditional serum antigen testing, NAT testing was more cost effective, more convenient for donors and resulted in a greater proportion of donated grafts being made available for transplant.
Similar content being viewed by others
References
Busch MP (2007) Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after 10 years. In: Dax EM, Farrugia A, Vyas GN (eds) Advances in transfusion safety—volume IV, vol 127. Developments in Biologicals, Karger, pp 87–112
Commission Directive (2006) Available via http://www.dh.gov.uk/en/Publichealth/Scientificdevelopmentgeneticsandbioethics/Tissue/Tissuegeneralinformation/DH . Accessed 23 March 2009
Gie GA, Linder L, Ling RS, Simon JP, Slooff TJ, Timperley AJ (1993) Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br 75(1):14–21
James V (2005) Chapter 10 Microbiology tests for donors and donations: general specifications for laboratory test procedures. In: James V (ed) TSO, London Guidelines for the blood Transfusion Services in the United Kingdom, 7th edn, pp 137–141
Lee SH, Tseng SC (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303–312
Acknowledgments
We would like to thank NHSBT Brentwood Testing Laboratory, especially Steven Tassen for all their hard work, which enabled NAT testing to be implemented with TS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Westby, J., Lomas, R.J. & Kearney, J.N. The implementation of nucleic acid amplification technology testing for living tissue donors. Cell Tissue Bank 11, 205–208 (2010). https://doi.org/10.1007/s10561-009-9156-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-009-9156-x